WO2007019393A3 - Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties - Google Patents

Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties Download PDF

Info

Publication number
WO2007019393A3
WO2007019393A3 PCT/US2006/030622 US2006030622W WO2007019393A3 WO 2007019393 A3 WO2007019393 A3 WO 2007019393A3 US 2006030622 W US2006030622 W US 2006030622W WO 2007019393 A3 WO2007019393 A3 WO 2007019393A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosage forms
improved properties
polymer blends
providing improved
osmotic dosage
Prior art date
Application number
PCT/US2006/030622
Other languages
French (fr)
Other versions
WO2007019393A2 (en
Inventor
David E Edgren
Shu Li
Gurdish K Bhatti
Patrick S L Wong
Original Assignee
Alza Corp
David E Edgren
Shu Li
Gurdish K Bhatti
Patrick S L Wong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp, David E Edgren, Shu Li, Gurdish K Bhatti, Patrick S L Wong filed Critical Alza Corp
Priority to EP06789476A priority Critical patent/EP1912622A2/en
Priority to JP2008525263A priority patent/JP2009507774A/en
Publication of WO2007019393A2 publication Critical patent/WO2007019393A2/en
Publication of WO2007019393A3 publication Critical patent/WO2007019393A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Abstract

Disclosed are osmotic dosage forms including an osmotic core; a semi¬ permeable membrane that surrounds the osmotic core and comprises a blend of a cellulose acetate polymer and an acrylate copolymer; and an exit formed through the semi-permeable membrane. Also disclosed are methods of making and administering such dosage forms.
PCT/US2006/030622 2005-08-04 2006-08-04 Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties WO2007019393A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP06789476A EP1912622A2 (en) 2005-08-04 2006-08-04 Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
JP2008525263A JP2009507774A (en) 2005-08-04 2006-08-04 Osmotic dosage form comprising a semi-permeable membrane with a polymer mixture providing improved properties

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70593405P 2005-08-04 2005-08-04
US60/705,934 2005-08-04

Publications (2)

Publication Number Publication Date
WO2007019393A2 WO2007019393A2 (en) 2007-02-15
WO2007019393A3 true WO2007019393A3 (en) 2007-05-31

Family

ID=37155365

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/030622 WO2007019393A2 (en) 2005-08-04 2006-08-04 Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties

Country Status (4)

Country Link
US (1) US20070031496A1 (en)
EP (1) EP1912622A2 (en)
JP (1) JP2009507774A (en)
WO (1) WO2007019393A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US8518440B2 (en) 2010-12-21 2013-08-27 Confluent Surgical, Inc. Biodegradable osmotic pump implant for drug delivery
JP6041823B2 (en) 2013-03-16 2016-12-14 ファイザー・インク Tofacitinib oral sustained release dosage form
US11311488B2 (en) * 2020-06-10 2022-04-26 Auspex Pharmaceuticals, Inc. Osmotic dosage forms comprising deutetrabenazine and methods of use thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
WO2001051035A1 (en) * 2000-01-14 2001-07-19 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
WO2004010981A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Methods and dosage forms for controlled delivery of paliperidone
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3995631A (en) * 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4207893A (en) * 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
CH645391A5 (en) * 1978-02-21 1984-09-28 Ciba Geigy Ag POLYMERS WITH SUCCINYLSBERSTEINSÄUREESTERESRESTE.
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US5082668A (en) * 1983-05-11 1992-01-21 Alza Corporation Controlled-release system with constant pushing source
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4863456A (en) * 1986-04-30 1989-09-05 Alza Corporation Dosage form with improved delivery capability
US5019379A (en) * 1987-07-31 1991-05-28 Massachusetts Institute Of Technology Unsaturated polyanhydrides
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5160743A (en) * 1988-04-28 1992-11-03 Alza Corporation Annealed composition for pharmaceutically acceptable drug
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
US5006346A (en) * 1988-04-28 1991-04-09 Alza Corporation Delivery system
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
US4902514A (en) * 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US5091190A (en) * 1989-09-05 1992-02-25 Alza Corporation Delivery system for administration blood-glucose lowering drug
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5252338A (en) * 1991-06-27 1993-10-12 Alza Corporation Therapy delayed
US5190765A (en) * 1991-06-27 1993-03-02 Alza Corporation Therapy delayed
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system
DE69425453T2 (en) * 1993-04-23 2001-04-12 Novartis Ag Drug delivery device with controlled release
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
US20030125714A1 (en) * 2001-12-18 2003-07-03 Edgren David Emil Dosage form for time-varying patterns of drug delivery

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US5595759A (en) * 1994-11-10 1997-01-21 Alza Corporation Process for providing therapeutic composition
WO2001051035A1 (en) * 2000-01-14 2001-07-19 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
WO2004010981A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Methods and dosage forms for controlled delivery of paliperidone
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JEDRAS Z: "ONE-COMPARTMENT GASTROINTESTINAL THERAPEUTIC SYSTEM FOR CHLORPROMAZINE HYDROCHLORIDE", ACTA PHARMACEUTICA JUGOSLAVICA, vol. 37, no. 2, 1987, pages 149 - 154, XP009081318, ISSN: 0001-6667 *

Also Published As

Publication number Publication date
US20070031496A1 (en) 2007-02-08
JP2009507774A (en) 2009-02-26
EP1912622A2 (en) 2008-04-23
WO2007019393A2 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
WO2007019393A3 (en) Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
WO2008103599A3 (en) Composition, its use in the preparation of membranes, and systems comprising the membranes
WO2006128620A3 (en) Coupling for a multi-part dental implant system
WO2008093654A1 (en) Hollow-fiber membrane and hollow-fiber-membrane module having the same included therein
WO2007135689A3 (en) Membranes, coatings and films and methods for their preparation
WO2007127890A3 (en) Structured films having acoustical absorbance properties
WO2007135193A3 (en) Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
BRPI0919266A2 (en) device and method for transmitting an audio signal to a user, methods for manufacturing a device for transmitting an audio signal to the user, and for providing an audio device for a user, and device and method for transmitting a sound for a user. user having a tympanic membrane
EP2085443A4 (en) Process for producing resin porous membrane with adhesive layer, resin porous membrane with adhesive layer, and filter member
WO2008022932A3 (en) Controlled release system and method for manufacturing the same
WO2009151709A3 (en) Spiral wound membrane module for forward osmotic use
DE602005001783D1 (en) Hydrogen-permeable membrane and process for its preparation
SG135037A1 (en) Composite semipermeable membrane, and production process thereof
ZA201007500B (en) Improved method for making sulfonated block copolymers, method for making membranes from such block copolymers and membrane structures
GB2454385B (en) Mixed matrix membranes with small pore molecular sieves and methods for making and using the membranes
EP1926544A4 (en) Preparation method of polyamide thin film composite reverse osmosis membrane and polyamide thin film composite reverse osmosis membrane prepared therefrom
WO2011073796A3 (en) Codon-optimzed hepatitis b virus core antigen (hbcag)
MY144159A (en) Membrane post treatment
WO2008149440A1 (en) Medicinal film preparation with rapidly dissolving property and flexibility
EP2144695A4 (en) Modified porous membranes, methods of membrane pore modification, and methods of use thereof
SG131871A1 (en) Ultrafiltration membranes and methods of making and use of ultrafiltration membranes
WO2008002905A3 (en) Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
WO2008063780A3 (en) Vascular grafts with multiple channels and methods for making
WO2006044077A3 (en) Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
EP1907445A4 (en) Polyamide reverse osmosis composite membrane and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2008525263

Country of ref document: JP

Ref document number: 2006789476

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE